# Besifloxacin in Bacterial Keratitis

> **NCT02497365** · NA · COMPLETED · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 32 (actual)

## Conditions studied

- Bacterial Keratitis

## Interventions

- **DRUG:** Besifloxacin
- **DRUG:** Tobramycin and Cefazolin

## Key facts

- **NCT ID:** NCT02497365
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2019-06
- **Final completion:** 2019-07
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497365, "Besifloxacin in Bacterial Keratitis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02497365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*